Patents by Inventor Wai-Bing Mak

Wai-Bing Mak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assay for detecting hepatitis B virus (HBV)
    Patent number: 11028439
    Abstract: The disclosure is directed to methods, kits, and compositions, for amplifying and detecting a human hepatitis B virus (HBV) in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: June 8, 2021
    Assignee: ABBOTT MOLECULAR INC.
    Inventors: Dominik Duelli, Wai-Bing Mak, Brian Erickson, Amanda Goldston
  • Maximizing DNA yield of blood specimens collected in rapid clot tubes
    Patent number: 11015186
    Abstract: The invention provides methods for isolating DNA from a blood sample collected into tubes containing a rapid clot activator, which involves the use of a lysis buffer comprising an alcohol.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: May 25, 2021
    Assignee: Abbott Molecular Inc.
    Inventors: Wai-Bing Mak, Dominik Duelli, Shihai Huang
  • SYSTEMS AND METHODS FOR ISOLATING NUCLEIC ACIDS
    Publication number: 20200232014
    Abstract: The present disclosure relates to systems and methods for nucleic acid isolation. In particular, the present disclosure provides systems and methods for isolating low molecular weight circulating nucleic acids from bodily fluids (e.g., plasma).
    Type: Application
    Filed: April 1, 2020
    Publication date: July 23, 2020
    Inventors: Gerard Gundling, Robert Kowal, Edward Granados, Natalie Solomon, Wai-Bing Mak, Magdalena Szostak
  • Systems and methods for isolating nucleic acids
    Patent number: 10640808
    Abstract: The present disclosure relates to systems and methods for nucleic acid isolation. In particular, the present disclosure provides systems and methods for isolating low molecular weight circulating nucleic acids from bodily fluids (e.g., plasma).
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: May 5, 2020
    Assignee: Abbott Molecular Inc.
    Inventors: Gerard Gundling, Robert Kowal, Edward Granados, Natalie Solomon, Wai-Bing Mak, Magdalena Szostak
  • ASSAY FOR DETECTING HEPATITIS B VIRUS (HBV)
    Publication number: 20190153537
    Abstract: The disclosure is directed to methods, kits, and compositions, for amplifying and detecting a human hepatitis B virus (HBV) in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.
    Type: Application
    Filed: September 27, 2018
    Publication date: May 23, 2019
    Inventors: Dominik Duelli, Wai-Bing Mak, Brian Erickson, Amanda Goldston
  • MAXIMIZING DNA YIELD OF BLOOD SPECIMENS COLLECTED IN RAPID CLOT TUBES
    Publication number: 20180087049
    Abstract: The invention provides methods for isolating DNA from a blood sample collected into tubes containing a rapid clot activator, which involves the use of a lysis buffer comprising an alcohol.
    Type: Application
    Filed: September 7, 2017
    Publication date: March 29, 2018
    Inventors: Wai-Bing Mak, Dominik Duelli, Shihai Huang
  • SYSTEMS AND METHODS FOR ISOLATING NUCLEIC ACIDS
    Publication number: 20140272967
    Abstract: The present disclosure relates to systems and methods for nucleic acid isolation. In particular, the present disclosure provides systems and methods for isolating low molecular weight circulating nucleic acids from bodily fluids (e.g., plasma).
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Inventors: Gerard Gundling, Robert Kowal, Edward Granados, Natalie Solomon, Wai-Bing Mak, Magdalena Szostak
  • SYSTEMS AND METHODS FOR ISOLATING NUCLEIC ACIDS
    Publication number: 20140272968
    Abstract: The present disclosure relates to systems and methods for nucleic acid isolation. In particular, the present disclosure provides systems and methods for isolating low molecular weight circulating nucleic acids from bodily fluids (e.g., plasma).
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Applicant: Abbott Molecular Inc.
    Inventors: Gerard Gundling, Robert Kowal, Edward Granados, Natalie Solomon, Wai-Bing Mak, Magdalena Szostak